MetLife Investment Management’s Axon Enterprise AXON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.26M Sell
21,798
-647
-3% -$336K 0.05% 382
2025
Q4
$12.7M Sell
22,445
-502
-2% -$312K 0.06% 293
2025
Q3
$16.5M Buy
22,947
+692
+3% +$525K 0.08% 219
2025
Q2
$18.4M Buy
22,255
+278
+1% +$189K 0.11% 169
2025
Q1
$11.6M Sell
21,977
-351
-2% -$205K 0.06% 297
2024
Q4
$13.3M Buy
22,328
+390
+2% +$212K 0.07% 200
2024
Q3
$8.77M Sell
21,938
-328
-1% -$113K 0.05% 292
2024
Q2
$6.55M Buy
22,266
+2,865
+15% +$855K 0.04% 371
2024
Q1
$6.07M Sell
19,401
-595
-3% -$165K 0.04% 398
2023
Q4
$5.17M Sell
19,996
-267
-1% -$60.2K 0.04% 433
2023
Q3
$4.03M Sell
20,263
-434
-2% -$85.4K 0.03% 539
2023
Q2
$4.04M Sell
20,697
-22,845
-52% -$4.73M 0.03% 578
2023
Q1
$9.79M Sell
43,542
-1,105
-2% -$220K 0.07% 215
2022
Q4
$7.41M Sell
44,647
-887
-2% -$140K 0.06% 285
2022
Q3
$5.27M Sell
45,534
-2,712
-6% -$307K 0.04% 383
2022
Q2
$4.5M Buy
48,246
+1,137
+2% +$120K 0.03% 484
2022
Q1
$6.49M Buy
47,109
+15,281
+48% +$2.1M 0.04% 383
2021
Q4
$5M Buy
31,828
+276
+0.9% +$46.3K 0.04% 398
2021
Q3
$5.52M Sell
31,552
-769
-2% -$140K 0.05% 327
2021
Q2
$5.71M Sell
32,321
-626
-2% -$92.2K 0.05% 333
2021
Q1
$4.69M Sell
32,947
-1,829
-5% -$285K 0.04% 426
2020
Q4
$4.26M Sell
34,776
-1,567
-4% -$180K 0.04% 429
2020
Q3
$3.3M Sell
36,343
-966
-3% -$84K 0.04% 492
2020
Q2
$3.66M Sell
37,309
-20,922
-36% -$1.69M 0.04% 421
2020
Q1
$4.12M Sell
58,231
-991
-2% -$74.2K 0.06% 313
2019
Q4
$4.34M Sell
59,222
-402
-0.7% -$25.4K 0.05% 424
2019
Q3
$3.39M Sell
59,624
-2,058
-3% -$130K 0.04% 536
2019
Q2
$3.96M Buy
61,682
+36,462
+145% +$2.38M 0.04% 469
2019
Q1
$1.37M Hold
25,220
0.01% 955
2018
Q4
$1.1M Hold
25,220
0.01% 982
2018
Q3
$1.73M Buy
25,220
+1,773
+8% +$120K 0.02% 914
2018
Q2
$1.48M Buy
+23,447
New +$1.27M 0.02% 884
2018
Q1
Sell
-22,057
Closed -$585K 2191
2017
Q4
$585K Buy
+22,057
New +$530K 0.01% 1319

Other funds holding AXON

MetLife Investment Management's AXON Position: Q1 2026 in Review

MetLife Investment Management reduced its Axon Enterprise (AXON) stake by 2.9% in Q1 2026, selling an estimated $336K and leaving 21,798 shares worth $9.26M. The position accounts for 0.05% of the portfolio, ranked #382.

MetLife Investment Management first reported a position in AXON in Q4 2017 and has held it in 33 quarters since. The position peaked at $18.4M in Q2 2025. 1,048 funds tracked by Wall St. Rank hold AXON as of Q1 2026.

  • MetLife Investment Management held 21,798 shares of Axon Enterprise worth $9.26M as of Q1 2026.
  • MetLife Investment Management sold 647 Axon Enterprise shares in Q1 2026, an estimated $336K.
  • Axon Enterprise made up 0.05% of MetLife Investment Management's portfolio in Q1 2026, its #382 holding.
  • MetLife Investment Management first reported a position in Axon Enterprise in Q4 2017 and has held it in 33 quarters since.
  • MetLife Investment Management's Axon Enterprise position peaked at $18.4M in Q2 2025.
  • 1,048 funds tracked by Wall St. Rank held Axon Enterprise as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.